Evaluation of the Signal to Noise Ratio at Various Retinal Layers
NCT ID: NCT02982174
Last Updated: 2022-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2016-12-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Repeatability Between SS and SD-OCT for Measuring Retinal Thickness in Various Retinal Diseases
NCT03438903
OCT Agreement and Precision Study
NCT02045823
Agreement Between Spectral Domain and Time Domain Optical Coherence Tomography (OCT)
NCT00651989
Spectral-domain Optical Coherence Tomography of the Eye
NCT02614625
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Eyes
Subjects with no known ocular diseases will be imaged on the 3D OCT-1 Maestro and DRI OCT Triton
3D OCT-1 Maestro
Image acquisition of the posterior surface of the eye
DRI OCT Triton
Image acquisition of the posterior surface of the eye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D OCT-1 Maestro
Image acquisition of the posterior surface of the eye
DRI OCT Triton
Image acquisition of the posterior surface of the eye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date.
3. Subjects who agree to participate in the study.
Exclusion Criteria
2. Fixation problems which may prevent obtaining good quality images in either eye.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Topcon Medical Systems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei-Chieh Huang, PhD
Role: PRINCIPAL_INVESTIGATOR
Topcon Medical Systems, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Topcon Medical Systems Inc.
Oakland, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Topcon-601-2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.